You are here

Home

Analysis

Billions of dollars and 35 years of US investment in research led to development of mRNA COVID vaccines --study

Fri, 2023-03-03 10:35 — mike kraft
35 years of US investment in research led to development of mRNA COVID vaccines CIDRAP

In the three decades leading up to the pandemic, the US government invested $31.9 billion in research that supported the development of mRNA COVID-19 vaccines in 2020, $337 million of which was invested before the pandemic, finds a Brigham and Women's–led study published yesterday in The BMJ. ...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Treatments
Data
Disease
Disease Prevention
Government
Health
Mutations
Public Health
Research
Vaccinations
Economics
Problem, Solution, SitRep, or ?: 
Analysis

Long COVID: syudy suggests patients could benefit from treatment for concussion patients

Fri, 2023-03-03 09:48 — mike kraft
Long COVID patients could benefit from concussion treatment, DU study finds Concussions and long COVID have more in common than you might think, new research shows. Alayna Alvarez Axios
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Disease
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis

Long COVID: patients with it may have lower levels of brain oxygen, cognitive problems--2 studies

Fri, 2023-03-03 09:41 — mike kraft
Patients with long COVID may have lower levels of brain oxygen, cognitive problems - UPI.com People who have long COVID -- lingering symptoms after a COVID-19 infection -- may also have lower brain oxygen levels, cognitive problems and psychiatric troubles, such as anxiety and depression. UPI

...

Country / Region Tags: 
Canada
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Data
Disease
Health
Medical Testing
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Monovalent COVID booster protects well against Omicron, but it wanes over 6 months --study

Fri, 2023-03-03 09:36 — mike kraft
Monovalent COVID booster protects well against Omicron, but it wanes over 6 months The COVID-19 booster was 74% effective against Omicron infection compared with the primary vaccine series for 3 months, but protection waned to 36% after 6 months. CIDRAP
Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Boosters
Data
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

Vaccine may limit long-COVID impact but controlled trials needed --new studies

Thu, 2023-03-02 10:25 — mike kraft
Vaccine may limit long-COVID impact, studies show, but controlled trials needed CIDRAP

Two new observational studies suggest that COVID-19 vaccination lowers long-COVID incidence and severity, although the authors of a related commentary say trials comparing vaccination with a placebo are needed. The research was published yesterday in BMJ Medicine.

...

Country / Region Tags: 
Australia
France
Global
United Kingdom
United States
General Topic Tags: 
COVID-19
Symptoms
Contagion
Data
Disease
Disease Prevention
Health
Pandemics
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

New studies indicate high level of Covid in toilet samples of US-bound planes, and effectiveness of pre-departure testing

Thu, 2023-03-02 09:52 — mike kraft
81% of toilet samples from US-bound planes had Omicron RNA CIDRAP

Two new studies from Morbidity and Mortality Weekly Report highlight new findings about air travel amid COVID-19, with one showing that 81% of wastewater samples from airplane restrooms had SARS-CoV-2 Omicron variant genetic material in fall 2022, and the other suggesting that predeparture testing of international travelers was tied to a 52% lower positivity rate at arrival in the United States.

...

 

 

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
Travel
COVID-19
Contagion
Data
Disease
Health
Medical Testing
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Essential workers during pandemic did not get enough information to protect their health--study

Wed, 2023-03-01 10:11 — mike kraft
Covid-19 surveillance added new burdens on essential workers — and gave them little data to protect their health Surveillance technologies deployed during the Covid-19 pandemic added new burdens on essential workers — and gave them little data to protect their health. Ambar Castillo STAT

At the peak of the pandemic, essential workers faced rampant tech-based surveillance, from overhead infrared thermometers to wearables that tracked their proximity to one another.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Contagion
Government
Health
Medical Personnel
Public Health
Science
Communication
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Opinion: Their boards may be a reason that many nonprofit hospitals are failing Americans

Tue, 2023-02-28 10:37 — mike kraft
Nonprofit hospitals are failing Americans. Their boards may be a reason why The composition of the boards of nonprofit hospitals may contribute to the gap between rhetoric and reality with respect to health equity. Patrick Skerrett STAT
Country / Region Tags: 
United States
General Topic Tags: 
Disease Prevention
Government
Health
Hospitals
Medical Personnel
Public Health
Economics
Problem, Solution, SitRep, or ?: 
Analysis

EU regulator recommends against approval for Merck's COVID pill for adults

Tue, 2023-02-28 09:57 — mike kraft
EU regulator recommends against approval for Merck's COVID pill for adults The European Union's drug regulator said on Friday its Committee for Medicinal Products for Human Use has advised against market authorisation of the COVID-19 pill from Merck & Co Inc for treatment in adults. Reuters Reuters
Country / Region Tags: 
Europe
Global
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Long COVID: Eight out of 10 hospital COVID patients in Sweden still had symptoms at 2 years --study

Tue, 2023-02-28 09:41 — mike kraft
84% of hospital COVID patients in Sweden still had symptoms at 2 years CIDRAP

The vast majority—84.2%—of COVID-19 survivors in a Swedish cohort reported persistent symptoms affecting daily life 2 years after hospital release, according to a follow-up study published late last week in The Lancet Regional Health Europe.

Country / Region Tags: 
Europe
Global
Sweden
General Topic Tags: 
COVID-19
Symptoms
Data
Disease
Health
Hospitals
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Pages

Subscribe to Analysis
howdy folks
Page loaded in 0.860 seconds.